Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

137
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
137
Positron Emission Tomography01:29

Positron Emission Tomography

4.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
4.2K
Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

257
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
257
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

98
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
98
Isotopes and Radioisotopes01:28

Isotopes and Radioisotopes

8.6K
In the early 1900s, English chemist Frederick Soddy realized that an element could have atoms with different masses that were chemically indistinguishable. These different types are called isotopes — atoms of the same element that differ in mass. Isotopes differ in mass because they have different numbers of neutrons but are chemically identical because they have the same number of protons. Soddy was awarded the Nobel Prize in Chemistry in 1921 for this discovery.
An isotope containing...
8.6K
Imaging Studies I: CT and MRI01:14

Imaging Studies I: CT and MRI

257
Introduction: MRI and CT scans are crucial advancements in medical imaging techniques, playing a vital role in diagnosing conditions related to the gastrointestinal (GI) system. Each scan serves distinct purposes, targets specific areas, and requires unique nursing duties.
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
257

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of DaT-SPECT Imaging in the Evaluation of Progressive Supranuclear Palsy.

Life (Basel, Switzerland)·2026
Same author

CT-Based Radiomics in the Characterization of Solid Renal Tumors: A Systematic Review.

Cancers·2026
Same author

Radiolabeled Angiopep-2 Peptide Vector as a Preclinical Platform for Blood-Brain Barrier Targeting: Synthesis, Radiolabeling, and Preliminary In Vivo Biodistribution in Mice.

Journal of peptide science : an official publication of the European Peptide Society·2026
Same author

FDG-PET in the Evaluation of Primary Progressive Aphasia: A Narrative Review.

Medicina (Kaunas, Lithuania)·2026
Same author

The Role of Cytokines in Traumatic Brain Injury.

Biomedicines·2026
Same author

Surgical Treatment of Tethered Cord Syndrome by Release of Filum Terminalis: A Review.

Children (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 13, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

429

Nuclear Medicine and Cancer Theragnostics: Basic Concepts.

Vasiliki Zoi1, Maria Giannakopoulou1, George A Alexiou1,2

  • 1Neurosurgical Institute, University of Ioannina, 45110 Ioannina, Greece.

Diagnostics (Basel, Switzerland)
|October 14, 2023
PubMed
Summary

Cancer theragnostics combines diagnostic imaging and therapy using radiopharmaceuticals. This approach offers personalized care, early diagnosis, and improved cancer treatment outcomes.

Keywords:
cholangiocarcinomacolorectal cancergliomaneuroendocrine tumorsnuclear medicineprostate cancertheragnosticsthyroid cancer

More Related Videos

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.1K

Related Experiment Videos

Last Updated: Jul 13, 2025

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

429
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
07:59

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

8.9K
Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
10:04

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

12.1K

Area of Science:

  • Nuclear Medicine
  • Oncology
  • Radiopharmaceutical Chemistry

Background:

  • Cancer theragnostics integrates diagnostic imaging and radionuclide therapy.
  • It utilizes paired radiopharmaceuticals for targeted cancer treatment and imaging.
  • Clinical use of theragnostics in nuclear medicine is rapidly expanding.

Purpose of the Study:

  • To review emerging theragnostic molecules and molecular targets in human malignancies.
  • To highlight the potential of copper radionuclides as theragnostic agents.
  • To discuss advancements in personalized cancer care through theragnostics.

Main Methods:

  • Review of current literature on cancer theragnostics.
  • Focus on novel radionuclides and molecular targets (receptors, kinases, proteins).
  • Analysis of theragnostic applications in gliomas, thyroid, neuroendocrine, cholangiocarcinoma, and prostate cancers.

Main Results:

  • Theragnostics offers advantages like simplified procedures, reduced side effects, and personalized patient care.
  • Emerging molecules target dysregulated pathways in various cancers.
  • Copper radionuclides show promise as alternatives to gallium-68 and lutetium-177.

Conclusions:

  • Cancer theragnostics represents a significant advancement in personalized oncology.
  • Continued research into novel radionuclides and targets will enhance efficacy.
  • Theragnostics facilitates early diagnosis, precise treatment, and improved patient outcomes.